Plenary Speakers

Dr. Wendy Burn – “Integrating Neuroscience Into Psychiatric Training in the United Kingdom: The Royal College of Psychiatrists Gatsby/Wellcome Neuroscience Project”

Professor Wendy Burn became a Consultant Old Age Psychiatrist in Leeds in 1990 and works part time in a community post. Her main clinical interest is dementia. She has held Regional leadership positions in this area and sits on National Groups for the planning of dementia care. She has been involved in the organisation and delivery of postgraduate training since she started as a consultant. She has held numerous roles in education and was the first Head of the Yorkshire School of Psychiatry. She has also had many educational positions within the College and was College Dean from 2011 to 2015. She became the Co-chair of the Gatsby Wellcome Neuroscience Project in 2015 and took up office as President of the College in 2017.

Dr. Stephen Kingsmore – “Implementing Genomic Medicine for Genetic Diseases in Children in Intensive Care Units”

Stephen F. Kingsmore is President and CEO of Rady Children’s Institute for Genomic Medicine at Rady Children’s Hospital, San Diego, which is implementing pediatric genomic/precision medicine at unprecedented scale. Previously he was the Dee Lyons/Missouri Endowed Chair in Genomic Medicine at the University of Missouri-Kansas City School of Medicine and Director of the Center for Pediatric Genomic Medicine at Children’s Mercy Hospital, Kansas City. He has been the President and CEO of the National Center for Genome Resources, Santa Fe, New Mexico, Chief Operating Officer of Molecular Staging Inc., Vice President of Research at CuraGen Corporation, founder of GatorGen, and Assistant Professor at the University of Florida’s School of Medicine. Dr. Kingsmore received MB ChB BAO and DSc degrees from the Queen’s University of Belfast. He trained in clinical immunology in Northern Ireland and did residency in internal medicine and fellowship at Duke University Medical Center. He is a fellow of the Royal College of Pathologists. He was a MedScape Physician of the year in 2012, and received the 2013 Scripps Genomic Medicine award and 2013 ILCHUN prize of the Korean Society for Biochemistry and Molecular Biology. TIME magazine ranked his rapid genome diagnosis one of the top 10 medical breakthroughs of 2012. In March of 2015, Dr. Kingsmore surpassed his previous record in genetic sequencing by reducing the process to 26 hours which was recognized in April 2016 by Guinness World Record as the fastest genetic sequencing in the world.

Dr. Jonathan Pritchard – “The Omnigenic Architecture of Human Complex Traits”

Jonathan Pritchard is a professor at Stanford University and an HHMI investigator. He
grew up mainly in England, and studied at Penn State, Stanford and Oxford before joining the
faculty of the University of Chicago in 2001. He returned to Stanford to take his current position in
2013. His current work focuses on the genetic basis of variation in gene regulation and complex
traits in humans, and on human polygenic adaptation.

Dr. Kelly Caudle – “The Clinical Pharmacogenetics Implementation Consortium (CPIC) Clinical Practice Guidelines

Kelly E. Caudle, Pharm.D., Ph.D., BCPS is the Clinical Pharmacogenetics Implementation
Consortium (CPIC) Director. CPIC provides guidelines that enable the translation of genetic
laboratory test results into actionable prescribing decisions for specific drugs. To date, CPIC has
published 20 gene-based clinical guidelines. In this position, Dr. Caudle oversees the CPIC guideline
development process including the coordination of the guideline writing committees, the guideline
evidence reviews, and the writing of the guideline manuscript and supplement. Furthermore, Dr.
Caudle is based in the clinical pharmacogenetics group at St. Jude Children’s Research Hospital. Dr.
Caudle received her Pharm.D. and Ph.D. from The University of Tennessee Health Science Center
and completed an ASHP-accredited PGY2 residency at Le Bonheur Children’s Research Hospital.
She is also a board‐certified Pharmacotherapy Specialist. Dr. Caudle is currently an affiliate
Assistant Professor at The University of Tennessee Health Science Center.

Dr. Chiara Fabbri – “Pharmacogenetic Testing in Psychiatry: Critical Review of Existing Testing Kits and Clinical Trials

Chiara Fabbri is a postdoctoral Marie Skłodowska-Curie fellow at Institute of Psychiatry,
Psychology and Neuroscience of King’s College London (UK).
She graduated in medicine and surgery at Bologna University (Italy), where she also completed her
specialization in psychiatry and started her academic career in neuroscience. She was interested in
pharmacogenetics since she was a medical student and this still remains one of the main topics of
her research activity. Dr. Fabbri always thought that clinical work as psychiatrist is important to
keep in mind patients’ perspective in research. She is author or co-author of more than 50 papers
published on peer-reviewed international journals, more than 40 poster or oral presentations at
international conferences, 9 book chapters.

Dr. Cynthia Bulik – “What Have We Been Missing? How Genetics is Guiding a Reconceptualization of Anorexia Nervosa”

Cynthia M. Bulik, Ph.D., FAED, is the Founding Director of the University of North
Carolina Center of Excellence for Eating Disorders, Distinguished Professor of Eating Disorders in
the Department of Psychiatry in the UNC School of Medicine, Professor of Nutrition in the Gillings
School of Global Public Health, and Professor in the Department of Medical Epidemiology and
Biostatistics at Karolinska Institutet in Stockholm, Sweden where she directs the Centre for Eating
Disorders Innovation.
A clinical psychologist, Dr. Bulik received her BA from the University of Notre Dame and her MA and
PhD from the University of California, Berkeley. She completed internships and post-doctoral
fellowships at Western Psychiatric Institute and Clinic in Pittsburgh. She was the lead PI of the
Anorexia Nervosa Genetics Initiative (ANGI) and is co-chair of the Eating Disorders Working Group
of the Psychiatric Genomics Consortium. She has active research collaborations in over twenty
countries and has published over 550 papers and chapters on eating disorders. She is author of
seven books including Crave, The Woman in the Mirror, Midlife Eating Disorders, and Binge Control:
A Compact Recovery Guide.

Dr. Naomi Wray 

Naomi Wray is Professor at the University of Queensland, Brisbane, Australia where she
is a Director of the Program in Complex Trait Genomics. She is an National Health and Medical
Research Council Principal Research Fellow, a Fellow of the Australian Academy of Science and on
the Board of ISPG. She has led analyses for several working groups of the Psychiatric Genomics

Dr. Francis McMahon – “From ApoE4 to Polygenic-Risk Scores: What’s New in the Prediction of Risk for Neuropsychiatric Conditions”

Dr. McMahon received a BA in Biology from the University of Pennsylvania and an MD
from Johns Hopkins, where he also completed a medical internship, a residency in adult psychiatry,
and a post-doctoral fellowship in genetics. After a stint at the University of Chicago, where he
continued his research into the genetics of bipolar disorder while serving as Medical Director of the
electroconvulsive therapy clinic, he joined the Mood and Anxiety Disorders Program of the National
Institute of Mental Health (NIMH) Intramural Research Program as Chief of its genetics unit, where
he is now Senior Investigator and Chief of the Human Genetics Branch. He is also a visiting
Professor of Psychiatry at the Johns Hopkins University School of Medicine.
Dr. McMahon is a past President of the International Society of Psychiatric Genetics and a Fellow in
the American College of Neuropsychopharmacology. He serves on the Editorial Boards of Biological
Psychiatry, the International Review of Psychiatry, and Molecular Neuropsychiatry, and is a
Scientific Advisor for the American Society for the Prevention of Suicide and the Rutgers University
Cell & DNA Repository. He has received many awards for his work, including the 2016 Colvin Mood
Disorders Prize from the Brain & Behavior Research Foundation. He has authored over 200 scientific
reports and textbook chapters.


Dr. Franziska Degenhardt – “Psychiatric Genetic Testing and Counselling – a European Perspective

Franziska Degenhardt is a board certified clinical geneticist at the Institute of Human
Genetics, University of Bonn, Germany (Head of department: Prof. Markus M. Nöthen). Her clinical
and research interests focus on the molecular basis of complex disease.
Since 2015, she has been head of a research group focusing on the identification of genetic risk
factors for psychosis. In 2017, she qualified as a senior lecturer in clinical genetics (Habilitation).
She has received several awards, including the Gershon Paper of the Year Award in 2016. Franziska
Degenhardt’s publication record includes more than 80 peer-reviewed articles on the genetics of
complex disease, including a first authorship publication in The Lancet. In the clinical context,
she provides genetic counselling to patients, families, and individuals at risk of genetic-related
disorders with particular focus on patients with a psychiatric disorder.
Since 2009, Franziska Degenhardt has been a member of the International Society of Psychiatric
Genetics (ISPG). In January 2018, she was appointed co-chair of the ISPG Genetic Testing
In April 2018, Franziska Degenhardt secured funding from the European Union for the
establishment of a pan-European network to Enhance Psychiatric Genetic Counselling, Testing, and
Training in Europe. Competition for this funding was intense, with only 8% of all applications being
successful. The network includes professionals from more than 20 countries. For the first time, a
critical mass of expertise from across Europe and beyond is assembled to develop a joint research
and clinical agenda for the implementation of the emerging disciplines of Psychiatric Genetic
Counselling and Psychiatric Genetic Testing in (future) routine psychiatric clinical practice and
professional training within Europe.

Dr. Sergiu Pasca – “Assembling Three-Dimensional Models of the Brain to Study Human Development and Disease”

Sergiu Pasca, MD is an Assistant Professor of Psychiatry and Behavioral Sciences at
Stanford University. He is also a NYSCF Roberston Stem Cell Investigator and the director of the
Stanford Neurosciences Stem Cell Program. Dr Pasca explores the biological underpinnings of
neuropsychiatric disease using cellular models of the human brain created by reprogramming
technologies. His laboratory developed approaches that allow to engineer from human stem cells
self-assembling 3D structures called brain region-specific spheroids or organoids. These organoids
resemble specific regions of the nervous system and can be fused in assembloids to study the
cellular cross-talk and model disease. Dr Pasca is the recipient of the Vilcek Award for Creative
Biomedical Promise, the Sammy Kuo Award for Neurosciences, the MQ Fellow Award for
Transforming Mental Health, the NIMH Director’s BRAINS Award and the Folch-Pi Award for